Utah Medical Products (UTMD) closed at $66.80 on October 29, 2026, down 3.0% from the previous close, on volume of 31,561 shares (30-day average 37,287).
Data as of October 29, 2026.
No headlines found.
Utah Medical Products, Inc. Reports Corrected Results of Tender Offer
ACCESS Newswire (Thu, 29-Oct 12:10 PM ET)
Utah Medical Products, Inc. Reports Results of Tender Offer
ACCESS Newswire (Thu, 29-Oct 8:30 AM ET)
UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2026
ACCESS Newswire (Thu, 22-Oct 9:00 AM ET)
Utah Medical Products, Inc. Extends Tender Offer
ACCESS Newswire (Mon, 5-Oct 8:30 AM ET)
Utah Medical Products, Inc. Clarifies Tender Offer Expiration Date
ACCESS Newswire (Fri, 25-Sep 11:00 AM ET)
Utah Medical Products, Inc. Commences Tender Offer
ACCESS Newswire (Thu, 24-Sep 4:45 PM ET)
UTMD Announces Self-Tender for 20% of Its Shares
ACCESS Newswire (Tue, 15-Sep 10:00 AM ET)
Femcare Ltd Acquires Orion Medical Supplies Ltd in the UK
ACCESS Newswire (Mon, 31-Aug 9:00 AM ET)
Utah Medical Products, Inc. Announces Quarterly Dividend
ACCESS Newswire (Tue, 4-Aug 10:00 AM ET)
Utah Medical Products Inc is involved in the business of developing, manufacturing, and distributing medical devices that are mainly proprietary, disposable, and for hospital use. The firm produces its products for Blood pressure monitoring, Blood collection, Electrosurgery, Gynecology, Neonatal critical care, perinatology, and Urology. The company's product portfolio includes Electrosurgical pens, Tenacula, Endoscopic bulb irrigators, and Blood bag spikes. Its products are used mainly in critical care areas, labor and delivery departments of hospitals, and outpatient clinics and physicians' offices.
Utah Medical Products trades on the NASDAQ stock market under the symbol UTMD.
As of October 29, 2026, UTMD stock price declined to $66.80 with 31,561 million shares trading.
UTMD has a beta of 0.33, meaning it tends to be less sensitive to market movements. UTMD has a correlation of 0.03 to the broad based SPY ETF.
UTMD has a market cap of $212.01 million. This is considered a Small Cap stock.
In the last 3 years, UTMD traded as high as $87.86 and as low as $51.26.
The top ETF exchange traded funds that UTMD belongs to (by Net Assets): VTI, IWM, DFSV, DFAT, VXF.
UTMD has outperformed the market in the last year with a return of +16.2%, while the SPY ETF gained +13.1%. However, in the most recent history, UTMD shares have underperformed the stock market with its stock returning -5.4% in the last 3 month period and -10.7% for the last 2 week period, while SPY has returned +4.1% and 0.0%, respectively.
UTMD support price is $67.59 and resistance is $70.09 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that UTMD shares will trade within this expected range on the day.